Neuberger Berman Group
IBB icon

Neuberger Berman Group’s iShares Biotechnology ETF IBB Stock Holding History

Neuberger Berman Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$392K Buy
2,324
+110
+5% +$18.8K ﹤0.01% 1722
2025
Q4 		$374K Buy
2,214
+61
+3% +$9.91K ﹤0.01% 1726
2025
Q3 		$311K Buy
2,153
+298
+16% +$40.7K ﹤0.01% 1746
2025
Q2 		$235K Sell
1,855
-164
-8% -$20.1K ﹤0.01% 1829
2025
Q1 		$258K Sell
2,019
-589
-23% -$79.9K ﹤0.01% 1744
2024
Q4 		$345K Sell
2,608
-515
-16% -$72.4K ﹤0.01% 1635
2024
Q3 		$455K Sell
3,123
-562
-15% -$81.3K ﹤0.01% 1549
2024
Q2 		$506K Buy
3,685
+120
+3% +$16K ﹤0.01% 1491
2024
Q1 		$489K Sell
3,565
-2,389
-40% -$326K ﹤0.01% 1506
2023
Q4 		$809K Sell
5,954
-361
-6% -$44K ﹤0.01% 1344
2023
Q3 		$772K Buy
6,315
+30
+0.5% +$3.81K ﹤0.01% 1326
2023
Q2 		$798K Buy
6,285
+2,691
+75% +$350K ﹤0.01% 1311
2023
Q1 		$464K Buy
3,594
+13
+0.4% +$1.7K ﹤0.01% 1484
2022
Q4 		$470K Buy
3,581
+61
+2% +$7.88K ﹤0.01% 1469
2022
Q3 		$411K Sell
3,520
-123
-3% -$15.3K ﹤0.01% 1522
2022
Q2 		$429K Buy
3,643
+120
+3% +$14.2K ﹤0.01% 1533
2022
Q1 		$459K Sell
3,523
-2,199
-38% -$286K ﹤0.01% 1562
2021
Q4 		$872K Buy
5,722
+328
+6% +$50.8K ﹤0.01% 1397
2021
Q3 		$872K Sell
5,394
-646
-11% -$109K ﹤0.01% 1342
2021
Q2 		$988K Sell
6,040
-1,440
-19% -$222K ﹤0.01% 1334
2021
Q1 		$1.13M Sell
7,480
-231
-3% -$36.7K ﹤0.01% 1290
2020
Q4 		$1.17M Sell
7,711
-600
-7% -$85.7K ﹤0.01% 1221
2020
Q3 		$1.13M Buy
8,311
+19
+0.2% +$2.58K ﹤0.01% 1187
2020
Q2 		$1.13M Buy
8,292
+3,422
+70% +$436K ﹤0.01% 1117
2020
Q1 		$524K Buy
4,870
+2,207
+83% +$254K ﹤0.01% 1231
2019
Q4 		$321K Buy
2,663
+25
+0.9% +$2.79K ﹤0.01% 1371
2019
Q3 		$262K Sell
2,638
-1,403
-35% -$147K ﹤0.01% 1405
2019
Q2 		$441K Buy
4,041
+995
+33% +$106K ﹤0.01% 1323
2019
Q1 		$341K Buy
3,046
+223
+8% +$24.5K ﹤0.01% 1341
2018
Q4 		$272K Sell
2,823
-385
-12% -$40.9K ﹤0.01% 1396
2018
Q3 		$391K Buy
3,208
+182
+6% +$21.4K ﹤0.01% 1364
2018
Q2 		$332K Sell
3,026
-206
-6% -$22K ﹤0.01% 1480
2018
Q1 		$345K Buy
3,232
+131
+4% +$14.5K ﹤0.01% 1438
2017
Q4 		$331K Buy
3,101
+44
+1% +$4.7K ﹤0.01% 1513
2017
Q3 		$340K Buy
3,057
+195
+7% +$20.8K ﹤0.01% 1386
2017
Q2 		$296K Sell
2,862
-60
-2% -$5.91K ﹤0.01% 1415
2017
Q1 		$286K Sell
2,922
-72,507
-96% -$6.94M ﹤0.01% 1434
2016
Q4 		$6.67M Buy
75,429
+71,637
+1,889% +$6.52M 0.01% 818
2016
Q3 		$366K Sell
3,792
-150
-4% -$14.3K ﹤0.01% 1343
2016
Q2 		$338K Sell
3,942
-15
-0.4% -$1.35K ﹤0.01% 1341
2016
Q1 		$344K Sell
3,957
-45
-1% -$4.02K ﹤0.01% 1336
2015
Q4 		$451K Sell
4,002
-192
-5% -$20.8K ﹤0.01% 1300
2015
Q3 		$424K Sell
4,194
-300
-7% -$36K ﹤0.01% 1310
2015
Q2 		$553K Sell
4,494
-321
-7% -$38.4K ﹤0.01% 1311
2015
Q1 		$551K Sell
4,815
-270
-5% -$29.8K ﹤0.01% 1327
2014
Q4 		$514K Buy
5,085
+1,050
+26% +$102K ﹤0.01% 1348
2014
Q3 		$368K Sell
4,035
-1,101
-21% -$96.6K ﹤0.01% 1416
2014
Q2 		$440K Sell
5,136
-123
-2% -$9.69K ﹤0.01% 1407
2014
Q1 		$414K Sell
5,259
-486
-8% -$40.5K ﹤0.01% 1372
2013
Q4 		$435K Sell
5,745
-439,179
-99% -$31.2M ﹤0.01% 1366
2013
Q3 		$31.1M Sell
444,924
-10,128
-2% -$664K 0.03% 509
2013
Q2 		$26.4M Buy
+455,052
New +$26.3M 0.03% 530

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Neuberger Berman Group's IBB Position: Q1 2026 in Review

Neuberger Berman Group increased its iShares Biotechnology ETF (IBB) stake by 5% in Q1 2026, buying an estimated $18.8K and bringing the position to 2,324 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1722.

Neuberger Berman Group first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.1M in Q3 2013. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Neuberger Berman Group held 2,324 shares of iShares Biotechnology ETF worth $392K as of Q1 2026.
  • Neuberger Berman Group bought 110 iShares Biotechnology ETF shares in Q1 2026, an estimated $18.8K.
  • iShares Biotechnology ETF made up ﹤0.01% of Neuberger Berman Group's portfolio in Q1 2026, its #1722 holding.
  • Neuberger Berman Group first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's iShares Biotechnology ETF position peaked at $31.1M in Q3 2013.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.